Clinical Use of a Carbohydrate-Restricted Diet to Treat the Dyslipidemia of the Metabolic Syndrome
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The metabolic syndrome is characterized by an atherogenic dyslipidemia identifiable using lipoprotein subclass analysis. This study assesses the effect of a carbohydrate-restricted diet on the dyslipidemia of the metabolic syndrome in a clinical setting. METHODS: This is a retrospective chart review of patients attending a preventive medicine clinic using lipoprotein subclass analysis (by NMR spectroscopy) to identify the atherogenic dyslipidemia. If present, patients were counseled to begin a carbohydrate-restricted diet (< 20 g/day). Patients already on statin therapy were included only if the medication dose was not changed. The outcomes were changes in body weight, fasting serum lipid profiles and serum lipoprotein subclasses. RESULTS: Of 122 patients identified, 80 patients had complete pre- and post-treatment data. The mean (+/-SD) age was 66 +/- 9 years, baseline weight was 85 +/- 12 kg, BMI was 28.1 +/- 3.6, 73% were male, 99% were Caucasian. Sixty-five percent were taking statin medication. Carbohydrate-restriction led to a 13% reduction in total cholesterol, 16% reduction in LDL cholesterol, 38% reduction in triglycerides, and a 13% increase in HDL cholesterol (all p values < 0.001). Carbohydrate-restriction also led to a reduction in LDL particle concentration of 28%, a reduction in small LDL of 82%, a reduction of large VLDL of 62%, and an increase in large HDL of 30% (all p values < 0.001). CONCLUSIONS: A carbohydrate-restricted diet recommendation led to improvements in lipid profiles and lipoprotein subclass traits of the metabolic syndrome in a clinical outpatient setting, and should be considered as a treatment for the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Emerging evidence suggests that LoCHO diets may actually have beneficial effects on LDL cholesterol by decreasing LDL particle concentration and increasing LDL size to less atherogenic form [25,28,70-73].”
From The case for low carbohydrate diets in diabetes management (2005) · cites this paper as [72]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Robins, S. J., Collins, D., Wittes, J. T., Papademetriou, V., Deedwania, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., Wexler, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 921
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896 · cited 1×
“20–22 However, the use of these serum tests for the prevention of atherosclerosis is not yet widely recommended.”
Brehm, B. J., Seeley, R. J., Daniels, S. R., & D’Alessio, D. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021480 · Cited by 830
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
Low-density lipoprotein subclass patterns and risk of myocardial infarction
Austin, M. A. (1988) · JAMA · doi:10.1001/jama.260.13.1917 · Cited by 414
Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409
Inhalation of levomepromazine in severe acute asthma
Pedersen, J. E., Olsen, A., & Banning, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91755-8 · Cited by 390
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345
Sondike, S. B., Copperman, N., & Jacobson, M. S. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.4 · Cited by 311
Kuller, L., Arnold, A., Tracy, R., Otvos, J., Burke, G., Psaty, B., Siscovick, D., Freedman, D. S., & Kronmal, R. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022015.97341.3a · Cited by 310
Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293
Range of serum cholesterol values in the population developing coronary artery disease
Kannel, W. B. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80474-3 · Cited by 289
Johansson, J., Carlson, L. A., Landou, C., & Hamsten, A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.174 · Cited by 260
Effect of 6-month adherence to a very low carbohydrate diet program
Westman, E. C., Yancy, W. S., Edman, J. S., Tomlin, K. F., & Perkins, C. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01129-4 · Cited by 252
Self-citationBody composition and hormonal responses to a carbohydrate-restricted diet
Volek, J. S., Sharman, M. J., Love, D. M., Avery, N. G., G[oacute]mez, A. L., Scheett, T. P., & Kraemer, W. J. (2002) · Metabolism · doi:10.1053/meta.2002.32037 · Cited by 250
Freed, M. I., Ratner, R., Marcovina, S. M., Kreider, M. M., Biswas, N., Cohen, B. R., & Brunzell, J. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02659-0 · Cited by 238
Dejager, S., Bruckert, E., & Chapman, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40756-4 · Cited by 237
Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy
Otvos, J. D., Jeyarajah, E. J., & Bennett, D. W. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.3.377 · Cited by 232
Eat, Drink, and Be Healthy: The Harvard Medical School Guide to Healthy Eating
Willett, W. C., Skerrett, P. J., Giovannucci, E. L., & Callahan, M. (2001) · Medical Entomology and Zoology · Cited by 218
The role of small, dense low density lipoprotein (LDL): a new look
Packard, C., Caslake, M., & Shepherd, J. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00107-2 · Cited by 171
Atherosclerosis and arterial influx of lipoproteins
Nordestgaard, B. G., & Nielsen, L. B. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199408000-00002 · Cited by 126
McKenney, J. M., McCormick, L. S., Schaefer, E. J., Black, D. M., & Watkins, M. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01639-3 · Cited by 123
Mittendorfer, B., & Sidossis, L. S. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.5.892 · Cited by 121
Mackey, R. H., Kuller, L. H., Sutton‐Tyrrell, K., Evans, R. G., Holubkov, R., & Matthews, K. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02636-x · Cited by 116
Otvos, J. D., SHALAUROVA, I. Y., Freedman, D. S., & Rosenson, R. S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00544-5 · Cited by 93
Wilson, H. M., Patel, J. C., Russell, D., & SKINNER, E. R. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90046-7 · Cited by 82
Particle size: the key to the atherogenic lipoprotein?
RAJMAN, I., MAXWELL, S., CRAMB, R., & KENDALL, M. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068888 · Cited by 50
Diets and Clinical Coronary Events: The Truth Is Out There
Yancy, W. S., Westman, E. C., French, P. A., & Califf, R. M. (2003) · Circulation · doi:10.1161/01.cir.0000049205.35749.00 · Cited by 43
Self-citationDachet, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05411-b · Cited by 29
Cited by
Low-carbohydrate nutrition and metabolism
Westman, E. C., Feinman, R. D., Mavropoulos, J. C., Vernon, M. C., Volek, J. S., Wortman, J. A., Yancy, W. S., & Phinney, S. D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.276 · Cited by 379
“Two clinical studies from the United States used LCDs in conjunction with statin therapy (66, 67).”
MethodSelf-citationManagement of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification
Magkos, F., Yannakoulia, M., Chan, J. L., & Mantzoros, C. S. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141200 · Cited by 211
“Retrospective reviews of patient charts have strongly suggested that low-carbohydrate diets are very effective in reducing body weight and in improving glycemic control and lipid profile among diabetics (93, 161, 220).”
BackgroundThe effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 167
The case for low carbohydrate diets in diabetes management
Arora, S. K., & McFarlane, S. I. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-16 · Cited by 102
Delgado‐Lista, J., Pérez‐Martínez, P., García‐Ríos, A., Phillips, C. M., Williams, C. M., Gulseth, H. L., Helal, O., Blaak, E. E., Kiec-Wilk, B., Basu, S., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.027 · Cited by 57
“Dietary factors may influence most of the MetS criteria, with an unfavorable profile associated with increased intake of total energy, saturated fat, or sugar [2,3].”
Background
Metadata
- Authors
- Hickey, J. T., Hickey, L., Yancy, W. S., Hepburn, J., & Westman, E. C.
- Venue
- Metabolic Syndrome and Related Disorders
- Publisher
- SAGE Publications
- Published
- 2003-09
- Volume
- 1
- Issue
- 3
- Pages
- 227-232
- ISSN
- 1540-4196 (ISSN-L)
- 1557-8518
- OpenAlex
- W2252708878
- Cited by
- 14
- References
- 35
- Citations by year
- 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 2
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Metabolic Syndrome and Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- low-carbohydrate diet, metabolic syndrome, dyslipidemia, lipoprotein subclasses, NMR lipoprotein profiling, LDL particle size, triglycerides, HDL cholesterol, total cholesterol, statin therapy, dietary intervention, body weight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.